Development · 20 Sep 2026
3 publishers have reported this development. Each act of reporting is below, cited.
Shilpa Medicare stated that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at Unit VII of its Analytical Services Division in Hyderabad from September 16 to 18, 2026, which concluded with one procedural observation.
Shilpa Medicare Ltd announced that a USFDA surveillance inspection at its Analytical Services Division in Hyderabad concluded with one procedural observation.
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.